Department of
Immunology and Medicine: Research Efforts and Partners


Product Development 2010-2011
- Dihydroartemisinin-piperaquine malaria prophylaxis
- Pharmacokinetics-toxicology: new anti-malarial compounds
- Pre-clinical studies
- Archived serum screening – influenza antibodies
- Effect of 2 seasonal flu vaccine doses
- Adjuvant optimization
- P. vivax human challenge model
- JBAIDS: malaria and leptospirosis
Surveillance 2010-2011
- P. falciparum malaria
-
- in vivo artemisinin treatment responses
Bench Efforts 2010-2011
- Molecular
- Pf drug resistance
- Single gene candidates
- Genome wide association studies (GWAS)
- Parasite population analysis; gene flow
- Multiplicity of infection, polymorphic variant analysis
- G6PD
- G6 PD-deficiency prevalence in Cambodia
- Polymorphism analysis
- JBAIDS: malaria and leptospirosis
- Assay development / validation
- Partner with Idaho Technologies Incorporated (ITI)
- Clinical pathway to FDA approval
Royal Thai Army - Malaria Microscopy Training 2010
Partners
Thailand
Royal Thai Army
Ministry of Public Health
Mahidol University
Wellcome Trust
Cambodia
Royal Cambodian Armed Forces
National Center for Malaria Control
NAMRU-2
CDC - Technical Working Group - Influenza
International
US Universities: Maryland, South Florida, N Carolina, Mississippi
World Health Organization
World Wide Antimalarial Resistance Network
Medicines for Malaria Venture (MMV)
Industry
Med-Immune
Sigma-Tau
GlaxoSmithKline
Theraclone
Pfizer
Ranbaxy
(includes current and past)
Royal Thai Army
Joint efforts between US and Royal Thai Army components
- P. vivax human challenge model
- Border surveillance
- Treatment responses after standard of care
- Training: microscopy, drug sensitivity
Back
to Department of Immunology
|